The European Commission’s Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) is set to soon approve and/or adopt an opinion on its Guidance on the determination of Potential Health Effects of Nanomaterials Used in Medical Devices. It is expected to do so at its 6th Plenary Meeting, which will be held on 10-11 June 2014.
At its 5th Plenary meeting, held on 26 February 2014, SCENIHR members reviewed a draft version of this opinion and commented that ‘it is important to underline in what respect the present testing used for risk assessment of medical devices are or are not suitable for the case of nano materials’. It seems that the version viewed was a final draft.
SCENIHR is also working on an opinion on Nanosilver: safety, health and environmental effects and role in antimicrobial resistance. The 6th Plenary is set to review updates to it, and notes from the 5th Plenary indicate that ’31 comments were received from orgnaizations and individuals’ on a public consultation it held on the opinion; NIA contributed to this following a consultation period with its Membership.
Follow this link to read the draft agenda for SCENIHR’s 6th Plenary meeting, and minutes from the 5th Plenary meeting. Follow this link to read NIA’s response to the consultation on the Nanosilver opinion.